Remove BioTech Remove Drug Development Remove Health Information Remove Pharmaceuticals
article thumbnail

Patients and Industry: Starting Our New Life Together in 2023

Society for Participatory Medicine

The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. After all of this time and energy expended, it’s only right that patients would be witness to accountability of pharma/biotech to incorporate our collective voice.

BioTech 144
article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

It is key for pharmaceutical companies to recognize that efficiency does not override compliance, patient safety or regulatory standards. Health Economics Outcomes Research (HEOR) will become more common in decentralized clinical trials (DCTs). Dave Latshaw, CEO at BioPhy 1.